Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Genetics, low estrogen, and low iron levels contribute to female hair loss, with specific scalp signs indicating severity.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Strontium ranelate is no longer available for treatment.

Over-the-counter products can help with menopause symptoms, but be aware of their ingredients.